临床医学工程2024，Vol.31Issue(3)：325-326,2.DOI:10.3969/j.issn.1674-4659.2024.03.0325
依托泊苷联合奥沙利铂治疗非小细胞肺癌的临床效果
Clinical Effect of Etoposide Combined with Oxaliplatin in the Treatment of Non-Small Cell Lung Cancer
姚赛 1田永京2
作者信息
- 1. 南阳市肿瘤医院西药部,河南南阳 473000
- 2. 南阳市肿瘤医院胸外科,河南南阳 473000
- 折叠
摘要
Abstract
Objective To explore the clinical effect of etoposide combined with oxaliplatin in the treatment of non-small cell lung cancer(NSCLC).Methods 80 NSCLC patients admitted to our hospital from May 2019 to April 2021 were selected and divided into observation group and control group according to lottery method.The control group was treated with radiotherapy,and the observation group was treated with etoposide and oxaliplatin on the basis of the control group.The treatment effect,survival time and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 52.00％,higher than 25.00％in the control group(P＜0.05).The median survival time of observation group was longer than that of control group(P＜0.05).The incidences of myelosuppression and granulocytopenia in the observation group were 30.00％and 25.00％,respectively,higher than 10.00％and 7.50％in the control group(P＜0.05).Conclusions Etoposide combined with oxaliplatin and radiotherapy has ideal effect in the treatment of NSCLC,which can prolong the survival time of patients,but the incidence of adverse reactions are relatively high.关键词
依托泊苷/奥沙利铂/非小细胞肺癌Key words
Etoposide/Oxaliplatin/Non-small cell lung cancer分类
医药卫生引用本文复制引用
姚赛,田永京..依托泊苷联合奥沙利铂治疗非小细胞肺癌的临床效果[J].临床医学工程,2024,31(3):325-326,2.
